Jilin Aodong Yanbian Pharmaceutical Co., Ltd. announced a private placement of convertible bonds for gross proceeds of CNY 200,000,000 from returning investor Jilin Aodong Medicine Industry Group Co., Ltd on August 30, 2023. After the transaction, the company will own 727,717,286 shares representing a 99.99% of total issued share capital. The transaction has been approved at the 2nd session of the company?s 11th directorate and the 2nd session of the company?s 11th supervisory board.